The impact of steroid receptors in chemohormone resistant prostate cancer
Project/Area Number |
16K10992
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Urology
|
Research Institution | Akita University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
井上 高光 秋田大学, 医学系研究科, 准教授 (60375243)
黄 明国 秋田大学, 医学系研究科, 助教 (60448503)
|
Project Period (FY) |
2016-04-01 – 2019-03-31
|
Project Status |
Completed (Fiscal Year 2018)
|
Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2018: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | 前立腺癌 / ステロイド受容体 / 生化学的再発 / 化学療法 / アンドロゲン受容体 / プロゲステロン受容体 / Hippo経路 / 抗癌剤耐性 / ステロイドホルモン受容体 |
Outline of Final Research Achievements |
We assessed the impact of tissue biomarkers in patient with prostate cancer who underwent surgery after different neoadjuvant setting using tissue microarray analyses. We found that a high nuclear androgen receptor and a high nuclear YAP1 in residual cancer cells had a poor biochemical recurrence-free survival. Furthermore, The nuclear YAP1 expression was markedly higher in docetaxel resistant prostate cancer cells than that in parental cells.
|
Academic Significance and Societal Importance of the Research Achievements |
これまで報告されているアンドロゲン受容体発現と前立腺癌化学内分泌療法抵抗性の関係のみならず、近年腫瘍の治療抵抗性やステロイド受容体との関連が示唆されるHippo経路の中心的転写因子の発現が前立腺癌化学内分泌療法抵抗性に関連する可能性を見出した。本分子は術前化学内分泌療法後前立腺全摘を行った症例の組織バイオマーカーとなる可能性のみならず化学内分泌療法抵抗性機序解明の足がかりや新規治療の標的となる可能性がある。
|
Report
(4 results)
Research Products
(21 results)
-
-
-
[Journal Article] Incidence and location of positive surgical margin among open, laparoscopic and robot-assisted radical prostatectomy in prostate cancer patients: a single institutional analysis2018
Author(s)
Koizumi A, Narita S, Nara T, Takayama K, Kanda S, Numakura K, Tsuruta H, Maeno A, Huang M, Saito M, Inoue T, Tsuchiya N, Satoh S, Nanjo H, Habuchi T.
-
Journal Title
Jpn J Clin Oncol.
Volume: 48
Issue: 8
Pages: 765-770
DOI
Related Report
Peer Reviewed
-
[Journal Article] The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the "obesity paradox".2017
Author(s)
Ito R, Narita S, Huang M, Nara T, Numakura K, Takayama K, Tsuruta H, Maeno A, Saito M, Inoue T, Tsuchiya N, Satoh S, Habuchi T
-
Journal Title
PLoS One
Volume: 12
Issue: 2
Pages: e0171615-e0171615
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
[Journal Article] Host-related Risk Factors for Adherent Perinephric Fat in Healthy Individuals Undergoing Laparoscopic Living-donor Nephrectomy.2017
Author(s)
Narita, S., Kumazawa, T., Tsuchiya, N., Mingguo, H., Saito, M., Inoue, T., Tsuruta, H.,Numakura, K., Maeno, A., Nanjo, H., Satoh, S., Habuchi, T.
-
Journal Title
Surg Laparosc Endosc Percutan Tech.
Volume: 27
Issue: 4
Pages: e69-e73
DOI
Related Report
Peer Reviewed
-
[Journal Article] Altered miRNA expression in high-fat diet-induced prostate cancer progression.2016
Author(s)
Nara T, Narita S, Mingguo H, Yoshioka T, Koizumi A, Numakura K, Tsuruta H, Maeno A, Saito M, Inoue T, Tsuchiya N, Satoh S, Habuchi T
-
Journal Title
Carcinogenesis
Volume: 37
Pages: 1129-1137
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
-
[Presentation] Tissue biomarkers in patients with high-risk prostate cancer treated with neoadjuvant chemohormonal therapy.2018
Author(s)
Narita. S., Nara. T., Chiba. S., Kanda. S., Numakura. K., Saito. M., Inoue. T., Huang. M., Nanjo. H., Habuchi. T.
Organizer
第77回日本癌学会総会, 9月, 大阪
Related Report
-
[Presentation] Pure host-related risk factors for adherent perinephric fat in healthy individuals during laparoscopic renal surgery2017
Author(s)
Narita, S., Nara, T., Takayama, K., Numakura, K., Tsuruta, H., Maeno, A., Saito, M., Inoue, T., Satoh, S., Habuchi, T.
Organizer
The 112th Annual Meeting of the American Urological Association, May, Boston, USA.
Related Report
Int'l Joint Research
-
[Presentation] Impact of Hippo pathway protein expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancer.2017
Author(s)
Narita, S., Nara, T., Huang, M., Numakura, K., Tsuruta, H., Maeno, A., Saito, M., Inoue, T., Satoh, S., Habuchi, T.
Organizer
The 112th Annual Meeting of the American Urological Association, May, Boston, USA.
Related Report
Int'l Joint Research
-
-
-
-
[Presentation] ハイリスク前立腺癌に対する術前化学内分泌療法併用前立腺全摘の治療成績~手術単独療法とのpropensity score-matched analysis.2017
Author(s)
成田伸太郎, 奈良健平, 神田壮平, 鶴田大, 沼倉一幸, 齋藤満, 井上高光, 羽渕友則, 三塚浩二, 古家琢也, 川村貞文, 栃木達夫, 大山力, 荒井陽一.
Organizer
第55会日本癌治療学会学術総会
Related Report
-
[Presentation] Expression of steroid hormone receptors in residual cancer and stromal cells after neoadjuvant chemohormonal therapy with docetaxal for high-risk localized prostate cancer.2016
Author(s)
Narita, S., Nara, T., Huang, M., Numakura, K., Tsuruta, H., Maeno, A., Saito,M., Inoue, T., Tsuchiya, N., Nanjo, H., Satoh,S., Habuchi, T.
Organizer
The 111th annual meeting of the American Urological Association
Place of Presentation
San diego
Year and Date
2016-05-08
Related Report
Int'l Joint Research
-
-
-
-
-